Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease-Reference-Cited by-同舟云学术

Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease

Published:2016-02-24 Issue:3 Volume:21 Page:556-566
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Jo Helen E.¹²^ORCID,Corte Tamera J.¹²,Wort Stephen J.³,Eves Neil D.⁴,Piper Amanda¹⁵,Wainwright Claire⁶

Affiliation:

1. Department of Respiratory and Sleep Medicine; Royal Prince Alfred Hospital; Sydney New South Wales Australia

2. University of Sydney; Sydney New South Wales Australia

3. Department of Pulmonary Hypertension; Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London; London UK

4. Centre for Heart, Lung and Vascular Health, School of Health and Exercise Sciences, Faculty of Health and Social Development; University of British Columbia; Kelowna British Columbia Canada

5. Woolcock Institute of Medical Research; University of Sydney; Sydney New South Wales Australia

6. Lady Cilento Children's Hospital, School of Medicine; University of Queensland; Brisbane Queensland Australia

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.12749/fullpdf

Reference109 articles.

1. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline;Raghu;Am. J. Respir. Crit. Care Med,2015

2. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;N. Engl. J. Med.,2014

3. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;N. Engl. J. Med.,2014